EZH2 and central nervous system cancer: Accumulated evidence suggests that EZH2 is involved in tumorigenesis, affecting cell proliferation and apoptosis, epithelial to mesenchymal transition, invasion, and drug resistance in gliomas and other cancers.20, 21, 22, 23